You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence
|
|---|---|
| Published in |
Current opinion in cardiology, February 2024
|
| DOI | 10.1097/hco.0000000000001121 |
| Pubmed ID | |
| Authors |
Stormi E. Gale, Andrew Willeford, Katherine Sandquist, Kristin Watson |
| Abstract |
Iron deficiency is common in patients with heart failure, affecting up to half of ambulatory patients and an even greater percentage of patients admitted for acute decompensation. Iron deficiency in this population is also associated with poor outcomes, including worse quality of life in addition to increased hospitalizations for heart failure and mortality. Evidence suggests that patients with iron deficiency in heart failure may benefit from repletion with IV iron. In this review, we outline the etiology and pathophysiology of iron deficiency in heart failure as well as various iron formulations available. We discuss evidence for intravenous iron repletion with a particular focus on recent studies that have evaluated its effects on hospitalizations and mortality. Finally, we discuss areas of uncertainty and future study and provide practical guidance for iron repletion. In summary, there is overwhelming evidence that intravenous iron repletion in patients with iron deficiency in heart failure is both beneficial and safe. However, further evidence is needed to better identify which patients would most benefit from iron repletion as well as the ideal repletion strategy. |
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 2 | 7% |
| Guatemala | 2 | 7% |
| Germany | 2 | 7% |
| United States | 2 | 7% |
| Ethiopia | 2 | 7% |
| Egypt | 2 | 7% |
| Chile | 2 | 7% |
| Colombia | 1 | 4% |
| Ecuador | 1 | 4% |
| Other | 4 | 14% |
| Unknown | 8 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 82% |
| Practitioners (doctors, other healthcare professionals) | 3 | 11% |
| Scientists | 2 | 7% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2024.
All research outputs
#2,684,396
of 25,748,735 outputs
Outputs from Current opinion in cardiology
#64
of 1,380 outputs
Outputs of similar age
#39,275
of 351,338 outputs
Outputs of similar age from Current opinion in cardiology
#2
of 4 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,380 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,338 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.